Your browser doesn't support javascript.
loading
Hypothalamic-pituitary-adrenal axis recovery after treatment of Cushing's syndrome.
Balasko, Annemarie; Zibar Tomsic, Karin; Kastelan, Darko; Dusek, Tina.
Afiliación
  • Balasko A; Department of Endocrinology, University Hospital Center Zagreb, Zagreb, Croatia.
  • Zibar Tomsic K; Department of Endocrinology, University Hospital Center Zagreb, Zagreb, Croatia.
  • Kastelan D; School of Medicine University of Zagreb, Zagreb, Croatia.
  • Dusek T; Department of Endocrinology, University Hospital Center Zagreb, Zagreb, Croatia.
J Neuroendocrinol ; 34(8): e13172, 2022 08.
Article en En | MEDLINE | ID: mdl-35726348
After successful treatment for Cushing's syndrome (CS), secondary adrenal insufficiency develops as a result of the prior suppression of the hypothalamic-pituitary-adrenal (HPA) axis by excess cortisol in the body. Until the recovery of the HPA axis, glucocorticoid replacement therapy is required to enable normal functioning of the body and prevent adrenal crisis. Significant variation in the median time of recovery of the HPA axis is found in various cohorts of CS patients ranging from several weeks to years. Despite the use of physiological glucocorticoid replacement, after cure for CS, patients often experience symptoms of glucocorticoid withdrawal syndrome (GWS). The optimal glucocorticoid regimen to reduce GWS needs to be established and requires an individualized approach aiming to avoid overtreatment at one side and minimize the risk of undertreatment and possible adrenal crisis and GWS on the other side.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Insuficiencia Suprarrenal / Síndrome de Cushing Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Revista: J Neuroendocrinol Asunto de la revista: ENDOCRINOLOGIA / NEUROLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Croacia

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Insuficiencia Suprarrenal / Síndrome de Cushing Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Revista: J Neuroendocrinol Asunto de la revista: ENDOCRINOLOGIA / NEUROLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Croacia